Kyowa Kirin International plc.
Marwan Samara MBA, MCIPD, KFLA, MHFA has a diverse work experience spanning over two decades. Marwan currently serves as the HR Director | GCC at Kyowa Kirin International plc. Prior to this, they worked as the Group Head of HR | Global at International Media Investments from 2018 to 2021. From 2017 to 2018, they held the position of VP Talent & Organizational Development at IHS Towers. Marwan also served as the Regional HR & Talent Director | MEA (Middle East & Emerging Africa) at Dimension Data from 2010 to 2016. Before that, they worked at EY as the Lead, Human Capital Advisory | MENA from 2007 to 2010. Marwan's earlier experience includes serving as the Head of HR Operations | EMEA at ICS Financial Systems (ICSFS) from 2001 to 2007. With their extensive background in HR and talent management, Marwan brings valuable expertise to every organization they work with.
Marwan Samara earned an MBA in Human Resources from the New York Institute of Technology in 2009. Marwan obtained several additional certifications, including Mental Health First Aider (MHFA) from The LightHouse Arabia in 2023, Change Management for HR (CMHR) from the Human Capital Institute (HCI) in 2019, and Chartered MCIPD from CIPD in 2017. Marwan also holds certifications in Korn Ferry Leadership Architect (KFLA) from Korn Ferry in 2016, Strategic Human Resources from SHRM in 2014, and various certifications in change management, compensation & benefits, and performance management from Ernst & Young Global Consulting Services in 2009 and 2008.
This person is not in any offices
Kyowa Kirin International plc.
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients. At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.